ArticleJournal of comparative effectiveness research2023

Cost-effectiveness of imipenem/cilastatin/relebactam for hospital-acquired and ventilator-associated bacterial pneumonia.

Jaesh Naik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.